{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:08:03Z","timestamp":1790208483101,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010977","name":"Cognitive Neuroscience Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.toxicon.2023.107150","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T13:40:10Z","timestamp":1683121210000},"page":"107150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Early versus late injections of Botulinumtoxin type A in post-stroke spastic movement disorder: A literature review"],"prefix":"10.1016","volume":"229","author":[{"given":"J\u00f6rg","family":"Wissel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songjin","family":"Ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatol","family":"Kivi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.toxicon.2023.107150_bib1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MRR.0b013e328332f5e0","article-title":"The profile of patients and current practice of treatment of upper limb muscle spasticity with botulinum toxin type A: an international survey","volume":"33","author":"Bakheit","year":"2010","journal-title":"Int. J. Rehabil. Res."},{"key":"10.1016\/j.toxicon.2023.107150_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/B978-0-444-52901-5.00013-7","article-title":"The diagnosis and management of adults with spasticity","volume":"110","author":"Balakrishnan","year":"2013","journal-title":"Handb. Clin. Neurol."},{"issue":"6","key":"10.1016\/j.toxicon.2023.107150_bib3","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.rehab.2018.10.004","article-title":"The neurophysiology of deforming spastic paresis: a revised taxonomy","volume":"62","author":"Baude","year":"2019","journal-title":"Ann Phys Rehabil Med"},{"key":"10.1016\/j.toxicon.2023.107150_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/11795735211036576","article-title":"Early identification, intervention and management of post-stroke spasticity: expert consensus recommendations","volume":"13","author":"Bavikatte","year":"2021","journal-title":"J. Cent. Nerv. Syst. Dis."},{"issue":"9","key":"10.1016\/j.toxicon.2023.107150_bib5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/1545968317732668","article-title":"Agreed definitions and a shared vision for new standards in stroke recovery research: the stroke recovery and rehabilitation roundtable taskforce","volume":"31","author":"Bernhardt","year":"2017","journal-title":"Neurorehabilitation Neural Repair"},{"issue":"7","key":"10.1016\/j.toxicon.2023.107150_bib6","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/jnnp.57.7.773","article-title":"Pathophysiology of spasticity","volume":"57","author":"Brown","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3 Suppl 2","key":"10.1016\/j.toxicon.2023.107150_bib7","first-page":"S20","article-title":"Pathophysiology of spasticity in stroke","volume":"80","author":"Burke","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.toxicon.2023.107150_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/1545968315585357","article-title":"Lesion characteristics of individuals with upper limb spasticity after stroke","volume":"30","author":"Cheung","year":"2016","journal-title":"Neurorehabilitation Neural Repair"},{"issue":"10","key":"10.1016\/j.toxicon.2023.107150_bib9","first-page":"960","article-title":"OnabotulinumtoxinA for lower limb spasticity: guidance from a delphi panel approach","volume":"9","author":"Esquenazi","year":"2017","journal-title":"Pharm. Manag. PM R"},{"issue":"9","key":"10.1016\/j.toxicon.2023.107150_bib10","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1212\/WNL.41.9.1505","article-title":"Plasticity of central motor pathways in children with hemiplegic cerebral palsy","volume":"41","author":"Farmer","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2023.107150_bib11","first-page":"54","article-title":"Modelling long-term outcomes and risk of death for patients with post-stroke spasticity receiving abobotulinumtoxina treatment and rehabilitation therapy","author":"Fheodoroff","year":"2022","journal-title":"J. Rehabil. Med."},{"issue":"8","key":"10.1016\/j.toxicon.2023.107150_bib12","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/ene.12381","article-title":"Early botulinum toxin treatment for spastic pes equinovarus--a randomized double-blind placebo-controlled study","volume":"21","author":"Fietzek","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.toxicon.2023.107150_bib13","series-title":"Clinical Pathways in Stroke Rehabilitation: Evidence-Based Clinical Practice Recommendations [Internet]","article-title":"Post-stroke spasticity. 2021 jan 15","author":"Francisco","year":"2021"},{"issue":"7","key":"10.1016\/j.toxicon.2023.107150_bib14","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/10749357.2020.1843845","article-title":"Early clinical predictors of post stroke spasticity","volume":"28","author":"Glaess-Leistner","year":"2021","journal-title":"Top. Stroke Rehabil."},{"issue":"5","key":"10.1016\/j.toxicon.2023.107150_bib15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/mus.20284","article-title":"Pathophysiology of spastic paresis. I: paresis and soft tissue changes","volume":"31","author":"Gracies","year":"2005","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.toxicon.2023.107150_bib16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ageing\/aft064","article-title":"Management of spasticity revisited","volume":"42","author":"Graham","year":"2013","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.toxicon.2023.107150_bib17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MRR.0b013e328353e3d4","article-title":"Classification of posture in poststroke upper limb spasticity: a potential decision tool for botulinum toxin A treatment?","volume":"35","author":"Hefter","year":"2012","journal-title":"Int. J. Rehabil. Res."},{"issue":"3","key":"10.1016\/j.toxicon.2023.107150_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0269215511421355","article-title":"An early botulinum toxin A treatment in subacute stroke patients may prevent a disabling finger flexor stiffness six months later: a randomized controlled trial","volume":"26","author":"Hesse","year":"2012","journal-title":"Clin. Rehabil."},{"issue":"3","key":"10.1016\/j.toxicon.2023.107150_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/2396987318771174","article-title":"Identifying unmet needs in long-term stroke care using in-depth assessment and the Post-Stroke Checklist - the Managing Aftercare for Stroke (MAS-I) study","volume":"3","author":"Hotter","year":"2018","journal-title":"Eur Stroke J"},{"issue":"7","key":"10.1016\/j.toxicon.2023.107150_bib20","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm.2399","article-title":"The immunology of stroke: from mechanisms to translation","volume":"17","author":"Iadecola","year":"2011","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.toxicon.2023.107150_bib21","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1016\/j.apmr.2019.10.038","article-title":"Early botulinum toxin injections for spasticity management post-stroke: a delphi-based Canadian consensus","volume":"100","author":"Ismail","year":"2019","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.toxicon.2023.107150_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1004629","article-title":"A practical guide to botulinum neurotoxin treatment of shoulder spasticity 1: anatomy, physiology, and goal setting","volume":"13","author":"Jacinto","year":"2022","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.toxicon.2023.107150_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/practneurol-2011-000155","article-title":"Spasticity: pathophysiology, evaluation and management","volume":"12","author":"Kheder","year":"2012","journal-title":"Pract Neurol"},{"issue":"1","key":"10.1016\/j.toxicon.2023.107150_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.apmr.2011.06.027","article-title":"Occurrence and temporal evolution of upper limb spasticity in stroke patients admitted to a rehabilitation unit","volume":"93","author":"Kong","year":"2012","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"4","key":"10.1016\/j.toxicon.2023.107150_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijge.2018.05.005","article-title":"Post-stroke spasticity: a review of epidemiology, pathophysiology, and treatments","volume":"12","author":"Kuo","year":"2018","journal-title":"Int. J. Gerontol."},{"issue":"4","key":"10.1016\/j.toxicon.2023.107150_bib26","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1191\/0269215504cr727oa","article-title":"Predicting spasticity after stroke in those surviving to 12 months","volume":"18","author":"Leathley","year":"2004","journal-title":"Clin. Rehabil."},{"issue":"1","key":"10.1016\/j.toxicon.2023.107150_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210038","article-title":"Which brain lesions produce spasticity? An observational study on 45 stroke patients","volume":"14","author":"Lee","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2023.107150_bib28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fnhum.2015.00192","article-title":"New insights into the pathophysiology of post-stroke spasticity","volume":"9","author":"Li","year":"2015","journal-title":"Front. Hum. Neurosci."},{"issue":"3","key":"10.1016\/j.toxicon.2023.107150_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/0269215520963855","article-title":"Can the early use of botulinum toxin in post stroke spasticity reduce contracture development? A randomised controlled trial","volume":"35","author":"Lindsay","year":"2021","journal-title":"Clin. Rehabil."},{"issue":"3","key":"10.1016\/j.toxicon.2023.107150_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/02692155221133522","article-title":"Estimating the cost consequence of the early use of botulinum toxin in post-stroke spasticity: secondary analysis of a randomised controlled trial","volume":"37","author":"Lindsay","year":"2023","journal-title":"Clin. Rehabil."},{"issue":"4","key":"10.1016\/j.toxicon.2023.107150_bib31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2340\/16501977-0509","article-title":"Time-course and determinants of spasticity during the first six months following first-ever stroke","volume":"42","author":"Lundstr\u00f6m","year":"2010","journal-title":"J. Rehabil. Med."},{"issue":"2","key":"10.1016\/j.toxicon.2023.107150_bib32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/0269215510381620","article-title":"Spasticity and contractures at the wrist after stroke: time course of development and their association with functional recovery of the upper limb","volume":"25","author":"Malhotra","year":"2011","journal-title":"Clin. Rehabil."},{"issue":"4","key":"10.1016\/j.toxicon.2023.107150_bib33","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1590\/S0004-282X2009000600013","article-title":"Predictive factors for spasticity among ischemic stroke patients","volume":"67","author":"Moura Rde","year":"2009","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.toxicon.2023.107150_bib34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fneur.2010.00149","article-title":"Spasticity mechanisms - for the clinician","volume":"1","author":"Mukherjee","year":"2010","journal-title":"Front. Neurol."},{"issue":"7\u20138","key":"10.1016\/j.toxicon.2023.107150_bib35","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s00221-020-05792-0","article-title":"Spastic movement disorder: should we forget hyperexcitable stretch reflexes and start talking about inappropriate prediction of sensory consequences of movement?","volume":"238","author":"Nielsen","year":"2020","journal-title":"Exp. Brain Res."},{"issue":"1","key":"10.1016\/j.toxicon.2023.107150_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1191\/0269215503cr587oa","article-title":"Contractures in the post-stroke wrist: a pilot study of its time course of development and its association with upper limb recovery","volume":"17","author":"Pandyan","year":"2003","journal-title":"Clin. Rehabil."},{"issue":"1\u20132","key":"10.1016\/j.toxicon.2023.107150_bib37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09638280400014576","article-title":"Spasticity: clinical perceptions, neurological realities and meaningful measurement","volume":"27","author":"Pandyan","year":"2005","journal-title":"Disabil. Rehabil."},{"issue":"5","key":"10.1016\/j.toxicon.2023.107150_bib38","first-page":"489","article-title":"Topical distribution of initial paresis of the limbs to predict clinically relevant spasticity after ischemic stroke: a retrospective cohort study","volume":"50","author":"Picelli","year":"2014","journal-title":"Eur. J. Phys. Rehabil. Med."},{"key":"10.1016\/j.toxicon.2023.107150_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/162754","article-title":"Association between severe upper limb spasticity and brain lesion location in stroke patients","volume":"2014","author":"Picelli","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"6","key":"10.1016\/j.toxicon.2023.107150_bib40","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/toxins13060374","article-title":"Early botulinum toxin type A injection for post-stroke spasticity: a longitudinal cohort study","volume":"13","author":"Picelli","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2023.107150_bib41","article-title":"[S2k-guideline : treatment of spastic syndrome","author":"Platz","year":"2019","journal-title":"DGNeurology]. German"},{"issue":"5","key":"10.1016\/j.toxicon.2023.107150_bib42","article-title":"Site and size of lesion predict post-stroke spasticity: a retrospective magnetic resonance imaging study","volume":"52","author":"Ri","year":"2020","journal-title":"J. Rehabil. Med."},{"issue":"3","key":"10.1016\/j.toxicon.2023.107150_bib43","doi-asserted-by":"crossref","DOI":"10.2340\/16501977-2803","article-title":"Early brain imaging predictors of post-stroke spasticity","volume":"53","author":"Ri","year":"2021","journal-title":"J. Rehabil. Med."},{"key":"10.1016\/j.toxicon.2023.107150_bib44","first-page":"131","article-title":"Why the nine hole peg test should not disappear from clinical stroke routine","volume":"4","author":"Ri","year":"2021","journal-title":"Int J Cerebrovasc Dis Stroke"},{"issue":"4","key":"10.1016\/j.toxicon.2023.107150_bib45","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00702-007-0869-3","article-title":"Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity","volume":"115","author":"Rosales","year":"2008","journal-title":"J. Neural. Transm."},{"issue":"7","key":"10.1016\/j.toxicon.2023.107150_bib46","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/1545968311430824","article-title":"Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial","volume":"26","author":"Rosales","year":"2012","journal-title":"Neurorehabilitation Neural Repair"},{"key":"10.1016\/j.toxicon.2023.107150_bib47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jns.2016.10.005","article-title":"Botulinum toxin as early intervention for spasticity after stroke or non-progressive brain lesion: a meta-analysis","volume":"371","author":"Rosales","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.toxicon.2023.107150_bib48","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3390\/toxins10070253","article-title":"Early AbobotulinumtoxinA (Dysport\u00ae) in post-stroke adult upper limb spasticity: ONTIME pilot study","volume":"10","author":"Rosales","year":"2018","journal-title":"Toxins"},{"issue":"5","key":"10.1016\/j.toxicon.2023.107150_bib49","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1310\/tsr1705-380","article-title":"Factors predictive of spasticity and their effects on motor recovery and functional outcomes in stroke patients","volume":"17","author":"Ryu","year":"2010","journal-title":"Top. Stroke Rehabil."},{"issue":"1","key":"10.1016\/j.toxicon.2023.107150_bib50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/01.STR.0000105386.05173.5E","article-title":"Spasticity after stroke: its occurrence and association with motor impairments and activity limitations","volume":"35","author":"Sommerfeld","year":"2004","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.toxicon.2023.107150_bib51","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/STROKEAHA.110.581991","article-title":"Occurrence and clinical predictors of spasticity after ischemic stroke","volume":"41","author":"Urban","year":"2010","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.toxicon.2023.107150_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2340\/16501977-0303","article-title":"European consensus table on the use of botulinum toxin type A in adult spasticity","volume":"41","author":"Wissel","year":"2009","journal-title":"J. Rehabil. Med."},{"issue":"7","key":"10.1016\/j.toxicon.2023.107150_bib53","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00415-010-5463-1","article-title":"Early development of spasticity following stroke: a prospective, observational trial","volume":"257","author":"Wissel","year":"2010","journal-title":"J. Neurol."},{"issue":"3 Suppl 2","key":"10.1016\/j.toxicon.2023.107150_bib54","first-page":"S13","article-title":"Toward an epidemiology of poststroke spasticity","volume":"80","author":"Wissel","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.toxicon.2023.107150_bib55","first-page":"60","article-title":"Post-stroke spasticity: predictors of early development and considerations for therapeutic intervention","volume":"7","author":"Wissel","year":"2015","journal-title":"Pharm. Manag. PM R"},{"issue":"11","key":"10.1016\/j.toxicon.2023.107150_bib56","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.apmr.2020.09.101","article-title":"Development of an early identification tool in post-stroke spasticity (PSS): the PSS risk classification system","volume":"101","author":"Wissel","year":"2020","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.toxicon.2023.107150_bib57","article-title":"BoNT A Therapy in the early acute phase following stroke to avoid disabling spascity","author":"Wissel","year":"2021","journal-title":"EFRR conference"},{"issue":"1","key":"10.1016\/j.toxicon.2023.107150_bib58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/14737175.2021.2021072","article-title":"Assessment, goal setting, and botulinum neurotoxin a therapy in the management of post-stroke spastic movement disorder: updated perspectives on best practice","volume":"22","author":"Wissel","year":"2022","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.toxicon.2023.107150_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.616097","article-title":"Prevalence and risk factors for spasticity after stroke: a systematic review and meta-analysis","volume":"11","author":"Zeng","year":"2021","journal-title":"Front. Neurol."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010123001368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010123001368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T05:15:09Z","timestamp":1736313309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010123001368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":59,"alternative-id":["S0041010123001368"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2023.107150","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early versus late injections of Botulinumtoxin type A in post-stroke spastic movement disorder: A literature review","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2023.107150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107150"}}